CPT code 55873 represents ultrasound-guided prostate cryoablation, a minimally invasive procedure that destroys cancerous prostate tissue by rapid freezing. Nationally, this code is important for tracking use of targeted prostate cancer treatments offered in outpatient surgical settings and for aligning clinical documentation with payer coverage and coding policies. Key payers in the national analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.

Readers will learn what the code represents clinically, where the service is typically provided, and the policy and billing context that commonly surrounds this procedure. The publication outlines typical sites of service, common billing considerations, and which payers are most relevant for coverage and claims adjudication. It also highlights benchmarks and policy updates where available and notes when data elements are not provided. This summary is intended for coding professionals, billing managers, and policy analysts seeking a concise reference on CPT code 55873 and its role in prostate cancer care pathways.